Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome.

BACKGROUND Patients with Marfan syndrome (MFS) have a highly variable occurrence of aortic complications. Aortic tortuosity is often present in MFS and may help to identify patients at risk for aortic complications. METHODS 3D-visualization of the total aorta by MR imaging was performed in 211 adult MFS patients (28% with prior aortic root replacement) and 20 controls. A method to assess aortic tortuosity (aortic tortuosity index: ATI) was developed and reproducibility was tested. The relation between ATI and age, and body size and aortic dimensions at baseline was investigated. Relations between ATI at baseline and the occurrence of a clinical endpoint (aortic dissection, and/or aortic surgery) and aortic dilatation rate during 3 years of follow-up were investigated. RESULTS ATI intra- and interobserver agreements were excellent (ICC: 0.968 and 0.955, respectively). Mean ATI was higher in 28 age-matched MFS patients than in the controls (1.92 ± 0.2 vs. 1.82 ± 0.1, p=0.048). In the total MFS cohort, mean ATI was 1.87 ± 0.20, and correlated with age (r=0.281, p<0.001), aortic root diameter (r=0.223, p=0.006), and aortic volume expansion rate (r=0.177, p=0.026). After 49.3 ± 8.8 months follow-up, 33 patients met the combined clinical endpoint (7 dissections) with a significantly higher ATI at baseline than patients without endpoint (1.98 ± 0.2 vs. 1.86 ± 0.2, p=0.002). Patients with an ATI>1.95 had a 12.8 times higher probability of meeting the combined endpoint (log rank-test, p<0.001) and a 12.1 times higher probability of developing an aortic dissection (log rank-test, p=0.003) compared to patients with an ATI<1.95. CONCLUSIONS Increased ATI is associated with a more severe aortic phenotype in MFS patients.

[1]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[2]  M. Mack,et al.  How does the ascending aorta geometry change when it dissects? , 2014, Journal of the American College of Cardiology.

[3]  Paul A. Bottomley,et al.  19F magnetic resonance imaging , 1977 .

[4]  X. Jeunemaître,et al.  Arterial tortuosity syndrome: early diagnosis and association with venous tortuosity. , 2013, Journal of the American College of Cardiology.

[5]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[6]  M. Venturini,et al.  Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation , 2014, BMC Medical Genetics.

[7]  A. Zwinderman,et al.  Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping. , 2001, Radiology.

[8]  Jan G P Tijssen,et al.  Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. , 2004, European heart journal.

[9]  B. Mulder,et al.  Pregnancy and marfan syndrome: an ongoing discussion. , 2012, Journal of the American College of Cardiology.

[10]  Hirofumi Tanaka,et al.  Age-associated elongation of the ascending aorta in adults. , 2008, JACC. Cardiovascular imaging.

[11]  A. Zwinderman,et al.  Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome. , 2013, International journal of cardiology.

[12]  D. Bluemke,et al.  Age-related changes in aortic arch geometry: relationship with proximal aortic function and left ventricular mass and remodeling. , 2011, Journal of the American College of Cardiology.

[13]  A. Zwinderman,et al.  The risk for type B aortic dissection in Marfan syndrome. , 2015, Journal of the American College of Cardiology.

[14]  Henk A Marquering,et al.  Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. , 2013, European heart journal.

[15]  P. Robinson,et al.  Total Serum Transforming Growth Factor‐β1 Is Elevated in the Entire Spectrum of Genetic Aortic Syndromes , 2014, Clinical cardiology.

[16]  B. Loeys,et al.  The Loeys–Dietz syndrome: an update for the clinician , 2010, Current opinion in cardiology.

[17]  David M. Williams,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.

[18]  Ella A. Kazerooni,et al.  Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease , 2010 .

[19]  A. Zwinderman,et al.  Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillance. , 2013, Radiology.

[20]  D. L. Newman,et al.  Arterial tortuosity. , 1990, Australasian physical & engineering sciences in medicine.

[21]  C. Wooley,et al.  The Marfan syndrome: abnormal aortic elastic properties. , 1991, Journal of the American College of Cardiology.

[22]  A. Yetman,et al.  The immediate and long-term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome. , 2012, Journal of the American College of Cardiology.

[23]  A. Gotlieb,et al.  Partial Off-Loading of Longitudinal Tension Induces Arterial Tortuosity , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Gauvreau,et al.  Increased Vertebral Artery Tortuosity Index Is Associated With Adverse Outcomes in Children and Young Adults With Connective Tissue Disorders , 2011, Circulation.

[25]  A. Zwinderman,et al.  The revised role of TGF-β in aortic aneurysms in Marfan syndrome , 2014, Netherlands Heart Journal.

[26]  R. Edelman,et al.  Magnetic resonance imaging (2) , 1993, The New England journal of medicine.

[27]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[28]  G. Dougherty,et al.  A quantitative index for the measurement of the tortuosity of blood vessels. , 2000, Medical engineering & physics.